Labels:text | screenshot | black and white | black | font | document OCR: ide is In the majority of acromegalics, if octre 300-600ug administered subcutaneously in doses els are per day (100-200ug eight hourly), GH le patients suppressed such that fifty-five per cent jared to have average levels below 10mu/l, com fourteen per cent with bromocriptine. pre In the same patients octreotide proves r nd, unlike effective than bromocriptine (Fig. 3.26) prolactin bromocriptine, causes no suppression o etory secretion except in some rare, mixed se mammosomatotroph tumours. Usually with carbohydrate tolerance does not worsen nt insulin octreotide administration, despite trans and suppression. Symptomatic relief is good headaches may be dramatically reduced
(.png)
